However, the only data published so far on cell line U-2946 describe the strong expression of ZAP70 and PKC-β II, a feature occurring in the more aggressive clinical form of non-GC DLBCL [39]. This evidence concerns the gene ZAP70 and diffuse large B-cell lymphoma.